VEGFA and macular retinal edema: Intravitreal injection of anti-VEGF agents was performed in 17 eyes (39.5%) due to macular edema (n=2), neovascular glaucoma (n=4), or as the pretreatment before pars plana vitrectomy (PPV) for complicated PDR (n=11).